NLRP3 and diabetes mellitus: TXNIP activates NLRP3 inflammasome complex formation, triggers mitochondrial stress-induced apoptosis and inflammatory cell death, as a potential therapeutic target in various diseases, such as diabetes, chronic kidney disease, and neurodegenerative diseases 30.